Status: Not yet recruiting
To Evaluate the Safety, Tolerability, Pharmacokinetics and the Effect of Food on the Hemay5259 Sustained-release Tablets in Healthy Subjects.
Evaluation of the pharmacokinetics of Hemay 5259 sustained-release tablets in healthy human subjects
Participants needed: 32
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Hemay Pharmaceutical PTY. LTD.Updated: Jul 15, 2026Locations: 1
Eligibility criteria
Must have given written informed consent before any study-related activities are... [+7]
Any history or presence of clinically relevant cardiovascular, pulmonary, gastro... [+26]